Nicole Risher

2.0k total citations
8 papers, 76 citations indexed

About

Nicole Risher is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Nicole Risher has authored 8 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Nicole Risher's work include RNA modifications and cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Nicole Risher is often cited by papers focused on RNA modifications and cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Nicole Risher collaborates with scholars based in United States and Switzerland. Nicole Risher's co-authors include Marla Weetall, Thomas W. Prior, Kathryn J. Swoboda, Phillip G. Zaworski, Katharine M. von Herrmann, Tara Newcomb, Karen Chen, Sergey Paushkin, Kathleen McCarthy and Sara Sunshine and has published in prestigious journals such as PLoS ONE, Cancer Research and Human Molecular Genetics.

In The Last Decade

Nicole Risher

8 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Risher United States 5 62 39 17 6 5 8 76
Cindy Zhang United States 5 54 0.9× 9 0.2× 3 0.2× 6 1.0× 12 2.4× 7 98
Dinko Stančić-Rokotov Croatia 6 24 0.4× 3 0.1× 24 1.4× 5 0.8× 3 0.6× 12 64
Marie Crahès France 7 37 0.6× 5 0.1× 18 1.1× 3 0.6× 10 74
John F. de Groot United States 3 15 0.2× 16 0.4× 3 0.2× 4 0.7× 1 0.2× 3 60
Anatoly Kustanovich Belarus 4 19 0.3× 14 0.4× 5 0.3× 2 0.4× 6 42
Shirin Barati Iran 3 18 0.3× 11 0.3× 4 0.2× 2 0.3× 5 37
Nadezhda Dalantaeva United Kingdom 3 11 0.2× 23 0.6× 18 1.1× 9 55
Maria Cristina Burlacu Belgium 5 21 0.3× 6 0.2× 17 1.0× 7 67
А. В. Попа Russia 4 12 0.2× 7 0.2× 5 0.3× 4 0.8× 19 54
Yoann Vial France 5 31 0.5× 5 0.1× 7 0.4× 8 1.6× 13 57

Countries citing papers authored by Nicole Risher

Since Specialization
Citations

This map shows the geographic impact of Nicole Risher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Risher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Risher more than expected).

Fields of papers citing papers by Nicole Risher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Risher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Risher. The network helps show where Nicole Risher may publish in the future.

Co-authorship network of co-authors of Nicole Risher

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Risher. A scholar is included among the top collaborators of Nicole Risher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Risher. Nicole Risher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ma, Jiyuan, Nicole Risher, Valerie Northcutt, et al.. (2021). Ataluren metabolism: Ataluren-O-1β-acyl glucuronide is a stable circulating metabolite in mouse, rat, dog and human. Drug Metabolism and Pharmacokinetics. 38. 100393–100393. 1 indexed citations
2.
Zhao, Xin, Zhihua Feng, Nicole Risher, et al.. (2021). SMN protein is required throughout life to prevent spinal muscular atrophy disease progression. Human Molecular Genetics. 31(1). 82–96. 6 indexed citations
3.
Ma, Jiyuan, Diksha Kaushik, Shirley Yeh, et al.. (2021). In vitro metabolism, pharmacokinetics and drug interaction potentials of emvododstat, a DHODH inhibitor. Xenobiotica. 52(2). 152–164. 7 indexed citations
4.
Zaworski, Phillip G., Katharine M. von Herrmann, Sara Sunshine, et al.. (2016). SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials. PLoS ONE. 11(3). e0150640–e0150640. 33 indexed citations
5.
Cao, Liangxian, Marla Weetall, Hongyan Qi, et al.. (2016). Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform. PLoS ONE. 11(12). e0168366–e0168366. 17 indexed citations
6.
Kim, Min Jung, Liangxian Cao, Josephine Sheedy, et al.. (2014). Abstract 5517: PTC596-induced Bmi1 hyper-phosphorylation via Cdk1/2 activation resulting in tumor stem cell depletion. Cancer Research. 74(19_Supplement). 5517–5517. 9 indexed citations
7.
Davis, Thomas W., Liangxian Cao, Nicole Risher, et al.. (2006). 52 POSTER Preclinical development of PTC299: an orally bioavailable small molecule drug that selectively inhibits the production of VEGF protein, tumor growth, and microvessel density. European Journal of Cancer Supplements. 4(12). 20–20. 1 indexed citations
8.
Saulnier, Muriel, et al.. (2005). Immunologic Pathways in a Quantitative Model of Immunosuppression Based on Rejection of an Allogeneic or Xenogeneic Tumor Graft. Transplantation. 79(8). 889–896. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026